Dutch test boosts prospects for photoacoustic breast imaging device

A new clinical device undergoing testing in the Netherlands uses photoacoustics, or light-induced sound, instead of radiation via X-rays to both detect and visualize breast tumors. Scientists at the University of Twente and Medisch Spectrum Twente Hospital in Oldenzaal are in the first phase of clinical testing for the device. So far, they've used it on 12 patients and determined it can identify cancerous tumors through high-contrast images. What's more, they found that the device offers a higher contrast of cancerous tissue than a regular X-ray mammography does. Details are published in the open-access journal Optical Express. Release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.